Allergy Asthma & Immunology Research

Scope & Guideline

Connecting research and practice in Allergy and Asthma.

Introduction

Delve into the academic richness of Allergy Asthma & Immunology Research with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN2092-7355
PublisherKOREAN ACAD ASTHMA ALLERGY & CLINICAL IMMUNOLOGY
Support Open AccessNo
CountrySouth Korea
TypeJournal
Convergefrom 2009 to 2024
AbbreviationALLERGY ASTHMA IMMUN / Allergy Asthma Immunol. Res.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRM 1705, KUMHO BLDG 327-2, CHANGSINDONG, JONGNO-GU, SEOUL 110-540, SOUTH KOREA

Aims and Scopes

The journal 'Allergy Asthma & Immunology Research' focuses on advancing knowledge in the field of allergic diseases, asthma, and immunological disorders. It emphasizes research that bridges clinical practice and scientific inquiry, aiming to improve patient outcomes through innovative therapies and management strategies.
  1. Allergic Diseases Research:
    The journal investigates various allergic conditions such as atopic dermatitis, food allergies, and allergic rhinitis, exploring their pathophysiology, risk factors, and management strategies.
  2. Asthma Pathophysiology and Management:
    Research on asthma encompasses its various phenotypes, mechanisms, and the efficacy of treatments, especially biologics and new therapeutic approaches.
  3. Immunological Mechanisms:
    Studies focus on the immune system's role in allergies and asthma, including the interplay between different immune cells and the impact of genetics and environmental factors.
  4. Biomarkers and Predictive Models:
    The journal emphasizes the identification of biomarkers for diagnosis, prognosis, and treatment response in allergic diseases and asthma, including novel predictive models.
  5. Therapeutic Innovations:
    Research on new therapeutic strategies, including biologics, immunotherapy, and dietary interventions, aimed at improving management and outcomes for patients with allergies and asthma.
The journal 'Allergy Asthma & Immunology Research' has shown a dynamic evolution in its research themes, highlighting emerging areas of interest and increasing trends that are reflective of current challenges and advancements in the field.
  1. Biologics and Targeted Therapies:
    There is a significant trend towards exploring the efficacy and safety of biologic therapies in severe asthma and allergic conditions, indicating a shift towards more targeted treatment strategies.
  2. Microbiome and Allergic Diseases:
    Research into the gut and nasal microbiome's role in the development and management of allergic diseases is gaining momentum, reflecting a growing interest in the microbiome's impact on immune responses.
  3. Artificial Intelligence in Allergy and Asthma:
    Emerging studies are utilizing artificial intelligence and machine learning for diagnostic purposes and treatment prediction, showcasing innovative approaches to allergy and asthma management.
  4. Longitudinal and Real-World Studies:
    An increase in longitudinal and real-world studies highlights the need for data that reflect actual patient experiences and treatment outcomes outside of controlled clinical trials.
  5. Environmental Influences on Allergic Diseases:
    There is a rising focus on how environmental factors, including pollution and climate change, affect the prevalence and severity of allergies and asthma, indicating a broader public health perspective.

Declining or Waning

Over recent years, certain themes within 'Allergy Asthma & Immunology Research' appear to be diminishing in frequency and prominence. These waning scopes may reflect shifts in research priorities or advancements that have rendered some areas less critical for exploration.
  1. Traditional Pharmacological Treatments:
    As the focus shifts towards biologics and precision medicine, traditional pharmacological treatments for asthma and allergies are receiving less attention in recent publications.
  2. Animal Models of Allergy:
    While animal models have historically played a crucial role in understanding allergic diseases, there seems to be a decline in studies emphasizing these models in favor of human-centric research.
  3. Generalized Allergy Management Guidelines:
    There is a noticeable reduction in papers discussing broad allergy management guidelines, as more research is focusing on personalized and targeted approaches tailored to individual patient needs.

Similar Journals

ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY

Connecting Asia-Pacific researchers for impactful discoveries.
Publisher: ALLERGY IMMUNOL SOC THAILANDISSN: 0125-877XFrequency: 4 issues/year

The ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, published by the Allergy Immunology Society of Thailand, is a pivotal platform for disseminating high-quality research in the fields of allergy and immunology. Established in 1983, this journal has consistently evolved to address the pressing challenges and advancements in these dynamic disciplines, contributing significantly to the global scientific community's understanding of immunological disorders. With a category ranking of Q3 in Immunology and Allergy, and Q2 in Medicine (miscellaneous) for 2023, the journal stands at the forefront of impactful research, engaging with a diverse audience of researchers, clinicians, and students alike. Although it operates on a non-open access model, its rigorous peer-review process ensures that published articles meet the highest academic standards. Located in Bangkok, Thailand, the journal connects researchers across the Asia-Pacific region, fostering collaboration and innovation to enhance patient care in the realm of allergy and immunology.

ALLERGY AND ASTHMA PROCEEDINGS

Bridging science and practice in respiratory medicine.
Publisher: OCEAN SIDE PUBLICATIONS INCISSN: 1088-5412Frequency: 6 issues/year

ALLERGY AND ASTHMA PROCEEDINGS, published by Ocean Side Publications Inc, is a vital resource in the fields of Immunology, Allergy, and Pulmonary Medicine. With an impressive trajectory of publication from 1996 to 2024, this journal serves as a platform for cutting-edge research and advancements in the understanding of allergic and asthmatic conditions. Positioned in the Q3 quartile for Immunology and Allergy and Q2 for both Medicine (miscellaneous) and Pulmonary Medicine, the journal exhibits a robust impact within the academic community, boasting Scopus rankings that reflect its significance. The journal offers open access options, allowing for the dissemination of critical findings to a wider audience. Aimed at researchers, healthcare professionals, and students alike, ALLERGY AND ASTHMA PROCEEDINGS addresses the complexities of respiratory diseases and facilitates the sharing of knowledge that is essential to improving patient care and outcomes.

CURRENT ALLERGY AND ASTHMA REPORTS

Delivering Critical Findings for Better Patient Outcomes
Publisher: CURRENT MEDICINE GROUPISSN: 1529-7322Frequency: 12 issues/year

CURRENT ALLERGY AND ASTHMA REPORTS, published by CURRENT MEDICINE GROUP, is a premier journal dedicated to advancing knowledge in the fields of allergy, asthma, and pulmonary medicine. With an impressive impact factor and a distinguished position in the Scopus ranking system—holding the 12th spot in Pulmonary and Respiratory Medicine and 40th in Immunology and Allergy—this journal is vital for researchers, clinicians, and healthcare professionals aiming to stay abreast of the latest developments and evidence-based practices. Since its inception in 2001, the journal has committed to publishing rigorous research articles, reviews, and expert opinion pieces that inform both clinical practice and research initiatives. Although it does not currently offer open access, it continues to maintain a robust platform for disseminating critical findings and fostering scholarly dialogue, ensuring it remains an essential resource for those dedicated to improving patient outcomes in respiratory health.

World Allergy Organization Journal

Connecting Global Research for Better Allergy Care
Publisher: ELSEVIERISSN: 1939-4551Frequency: 12 issues/year

World Allergy Organization Journal is a premier open-access publication dedicated to advancing the understanding and treatment of allergic diseases and related conditions. Published by ELSEVIER, this journal boasts a commendable impact factor and ranks in the second quartile for both Immunology and Allergy, as well as the first quartile in Pulmonary and Respiratory Medicine. Since its inception as an open-access journal in 2008, it has consistently aimed to provide a credible platform for researchers, clinicians, and students to disseminate original research, reviews, and clinical studies. With its emphasis on high-quality scholarship and practical applications, the World Allergy Organization Journal plays a crucial role in bridging theoretical knowledge with clinical practice, making significant contributions to the fields of immunology, allergy, and respiratory medicine. The journal is particularly notable for its accessibility to a global audience, exemplified by its open-access model since 2008, promoting a wider exchange of ideas and innovations across borders.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA

Innovating Understanding of Allergic Responses and Immune Mechanisms
Publisher: CODON PUBLICATIONSISSN: 0301-0546Frequency: 6 issues/year

ALLERGOLOGIA ET IMMUNOPATHOLOGIA is a distinguished academic journal dedicated to the field of immunology and allergy, published by CODON PUBLICATIONS, based in Singapore. With its ISSN 0301-0546 and E-ISSN 1578-1267, this journal aims to provide an open platform for researchers and practitioners to share their findings, emphasizing topics related to immunopathology and respiratory health. Covering a broad scope from 1973 to 2024, it currently holds a notable position in several category quartiles, including Q3 in Immunology and Allergy, and Q3 in Pulmonary and Respiratory Medicine as of 2023. Despite the absence of an open access option, the journal maintains an essential role in disseminating pivotal research, reflected in its Scopus rankings that position it within the core of its discipline. With an impact factor acknowledging the significance of its contributions, ALLERGOLOGIA ET IMMUNOPATHOLOGIA continues to be a vital resource for ongoing education and advancement in immunological and allergic research.

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Empowering Clinicians with Evidence-Based Knowledge
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0889-8561Frequency: 4 issues/year

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA is a premier journal published by W B SAUNDERS CO-ELSEVIER INC, focusing on the dynamic fields of immunology and allergy. With an ISSN of 0889-8561 and an E-ISSN of 1557-8607, this journal has consistently ranked in the Q2 category in both Immunology and Immunology and Allergy as per 2023 metrics, underscoring its critical role in academia. It provides cutting-edge research, comprehensive reviews, and practical insights that cater to the needs of researchers, clinicians, and students alike. Though the journal is not open access, it remains an essential resource for those involved in advancing knowledge and clinical practice in allergy and immunology. With its converged years stretching from 1987 to 2024, the journal serves as a rich repository of scientific advancements, fostering progress in diagnosis, treatment, and prevention of allergic diseases and immune disorders. Positioned within the United States and based in Philadelphia, it plays a vital role in promoting scholarly communication within these impactful fields.

Allergo Journal

Unveiling the complexities of immune disorders.
Publisher: SPRINGER HEIDELBERGISSN: 0941-8849Frequency: 8 issues/year

Welcome to the Allergo Journal, a pivotal publication in the field of Immunology and Allergy, housed under the esteemed SPRINGER HEIDELBERG publishing house. With an ISSN of 0941-8849 and E-ISSN 2195-6405, the journal has been serving the scientific community since its inception in 1994. Although its Scopus coverage was discontinued in 2017, the journal remains significant, ranked #135 out of 186 in its category and positioned in the 27th percentile, reflecting its contributions to vital research in allergy and immunological disorders. While the journal is not an open access publication, it continues to provide a platform for rigorous academic discourse and advances in the study of allergens and immune response. The Allergo Journal stands as a crucial resource for researchers, professionals, and students dedicated to deepening their understanding of allergies and immunology, fostering advancements in therapy and comprehensive patient care.

Alergologia Polska-Polish Journal of Allergology

Bridging research and practice in the field of allergology.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 2353-3854Frequency: 4 issues/year

Alergologia Polska - Polish Journal of Allergology, published by TERMEDIA PUBLISHING HOUSE LTD, is a distinguished academic journal dedicated to advancing the field of allergy research and treatment. With the ISSN 2353-3854, this journal serves as an essential resource for professionals, researchers, and students alike, offering a platform for the dissemination of novel findings and comprehensive reviews in allergic diseases. The journal emphasizes open access to ensure widespread availability and engagement within the scientific community. Alergologia Polska aims to enhance the understanding of allergy mechanisms, diagnostics, and management strategies, fostering collaboration and innovation among experts in the field. Set against the vibrant backdrop of Poznań, Poland, this publication not only highlights clinical and experimental research but also promotes interdisciplinary discussions that are pivotal for tackling complex allergic conditions globally.

Egyptian Journal of Pediatric Allergy and Immunology

Championing advancements in the understanding of pediatric allergies.
Publisher: EGYPTIAN SOC PEDIATRIC ALLERGY & IMMUNOLOGYISSN: 1687-1642Frequency: 2 issues/year

Welcome to the Egyptian Journal of Pediatric Allergy and Immunology, a leading academic platform dedicated to the advancement of knowledge in the field of pediatric allergy and immunology. Published by the prestigious Egyptian Society of Pediatric Allergy & Immunology, this journal aims to address the pressing challenges and breakthroughs in the diagnosis, treatment, and management of allergic diseases in children. As a crucial resource for researchers, healthcare professionals, and students, it focuses on disseminating high-quality, peer-reviewed articles that contribute to the global understanding of allergic conditions and immunological responses in pediatric populations. Although the journal is currently not an Open Access publication, it provides a valuable gateway to research findings that can shape clinical practice and influence future investigations. With an emphasis on contributing to improved healthcare outcomes for children suffering from allergy and immunology disorders, the Egyptian Journal of Pediatric Allergy and Immunology stands out as an essential reference in the field.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Connecting researchers to the latest in immunological advancements.
Publisher: MOSBY-ELSEVIERISSN: 0091-6749Frequency: 12 issues/year

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, published by MOSBY-ELSEVIER, stands as a leading peer-reviewed journal dedicated to advancing the understanding of allergies and immunological conditions. With a notable impact factor and a prominent stature in the academic community, it ranks in the Q1 category for both Immunology and Allergy in 2023, reflecting its significance and high citation rates among researchers. Since its establishment in 1963, the journal has fostered scientific discourse and innovation in the field, positioning itself as an essential resource for both seasoned professionals and emerging scholars. The Scopus rankings underscore its influence, being ranked 12th out of 233 in Immunology and Allergy and 15th out of 236 in Immunology and Microbiology, placing it in the top centile of both categories. The journal aims to disseminate cutting-edge research, reviews, and clinical studies that deepen our understanding of allergic diseases and enhance patient care. While not an open access journal, it provides institutions and individuals with opportunities to stay informed on crucial advancements in the immunological sciences.